← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS LTD · Approved 2024-12-19
Drug application
- FDA Application #
ANDA200406- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LAMIVUDINE
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- MICRO LABS LTD
- First approval
- 2024-12-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown